Tango Therapeutics, Inc.TNGXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-168.40%
↑ 45% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-303.72%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -168.40% | +50.5% |
| 2024 | -340.15% | -11.2% |
| 2023 | -305.96% | +30.5% |
| 2022 | -440.32% | -184.7% |
| 2021 | -154.67% | +76.5% |
| 2020 | -657.61% | -1016.4% |
| 2019 | -58.90% | - |